Concordance of a Laboratory-Data Integrated Fluid Targeting Algorithm with Bioimpedance-Derived Volume Measures in Maintenance Hemodialysis

BACKGROUND: Objective fluid assessment in hemodialysis often requires dedicated bioimpedance equipment. The Laboratory-Data Integrated Fluid Targeting algorithm uses routine biochemical and dialysis treatment data to estimate extracellular water, intracellular water, and euvolemic body weight. We evaluated its concordance with the Fresenius Body Composition Monitor and explored determinants of method differences. METHODS: In this prospective single-center study, 61 adults receiving stable maintenance hemodialysis for at least 3 months underwent paired assessment during one dialysis session. Agreement was evaluated using Pearson correlation, Deming regression, and Bland-Altman analysis. Exploratory multivariable models were used to examine age, sex, dialysis vintage, diabetes, heart failure, and ischemic heart disease. Clinically prescribed dry weight was analyzed as a separate clinical comparator. RESULTS: Extracellular-water estimates were strongly correlated (correlation coefficient, 0.87). The mean difference between the Laboratory-Data Integrated Fluid Targeting and Body Composition Monitor estimates was +0.22 L, with 95% limits of agreement from -4.1 to +4.6 L. The correlation for intracellular water was lower (correlation coefficient, 0.80), with a mean difference of +2.7 L and limits of agreement from -3.5 to +8.9 L. Estimated euvolemic weight was strongly correlated (correlation coefficient, 1.0 after rounding), although this partly reflected the shared body-weight component (mean difference, -0.67 kg; limits of agreement, -4.0 to +2.6 kg). Older age was associated with a smaller extracellular-water difference, whereas sex, dialysis vintage, diabetes, heart failure, and ischemic heart disease were not independently associated with method differences. CONCLUSIONS: The laboratory-based algorithm approximated Body Composition Monitor outputs at the cohort level; however, proportional bias and wide individual limits, particularly for intracellular water, preclude interchangeability. These findings support method concordance but do not constitute independent physiological or outcome validation. Clinical actionability and outcome benefit remain untested.

Authors

Institutions

Publication Details

Journal
Kidney360
Published
2026-11-16
DOI
https://doi.org/10.34067/kid.0000001468
Primary Topic
Dialysis and Renal Disease Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Concordance of a Laboratory-Data Integrated Fluid Targeting Algorithm with Bioimpedance-Derived Volume Measures in Maintenance Hemodialysis

Kazuhiko Shibata, Hiromichi Wakui, Yuki Kawai, Kouichi Tamura et al.
Kidney360
Dialysis and Renal Disease Management
article

Concordance of a Laboratory-Data Integrated Fluid Targeting Algorithm with Bioimpedance-Derived Volume Measures in Maintenance Hemodialysis

Kazuhiko Shibata, Hiromichi Wakui, Yuki Kawai, Kouichi Tamura, Ryo Shibata, Tamio Iwamoto, Takeshi Aoki, Sanae Saka, Kanenori Maeda, Hiroyoshi Fukui
article en

Abstract

BACKGROUND: Objective fluid assessment in hemodialysis often requires dedicated bioimpedance equipment. The Laboratory-Data Integrated Fluid Targeting algorithm uses routine biochemical and dialysis treatment data to estimate extracellular water, intracellular water, and euvolemic body weight. We evaluated its concordance with the Fresenius Body Composition Monitor and explored determinants of method differences. METHODS: In this prospective single-center study, 61 adults receiving stable maintenance hemodialysis for at least 3 months underwent paired assessment during one dialysis session. Agreement was evaluated using Pearson correlation, Deming regression, and Bland-Altman analysis. Exploratory multivariable models were used to examine age, sex, dialysis vintage, diabetes, heart failure, and ischemic heart disease. Clinically prescribed dry weight was analyzed as a separate clinical comparator. RESULTS: Extracellular-water estimates were strongly correlated (correlation coefficient, 0.87). The mean difference between the Laboratory-Data Integrated Fluid Targeting and Body Composition Monitor estimates was +0.22 L, with 95% limits of agreement from -4.1 to +4.6 L. The correlation for intracellular water was lower (correlation coefficient, 0.80), with a mean difference of +2.7 L and limits of agreement from -3.5 to +8.9 L. Estimated euvolemic weight was strongly correlated (correlation coefficient, 1.0 after rounding), although this partly reflected the shared body-weight component (mean difference, -0.67 kg; limits of agreement, -4.0 to +2.6 kg). Older age was associated with a smaller extracellular-water difference, whereas sex, dialysis vintage, diabetes, heart failure, and ischemic heart disease were not independently associated with method differences. CONCLUSIONS: The laboratory-based algorithm approximated Body Composition Monitor outputs at the cohort level; however, proportional bias and wide individual limits, particularly for intracellular water, preclude interchangeability. These findings support method concordance but do not constitute independent physiological or outcome validation. Clinical actionability and outcome benefit remain untested.

Kidney360
Kumamoto Orthopedic Surgery Hospital (JP), Nagoya Industries Promotion Corporation (JP), Saiseikai Yokohama-shi Nanbu Hospital (JP), Yokohama City University (JP)
Good health and well-being
Dialysis and Renal Disease Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon